Exploring Ferroptosis Biology
The Henry lab focuses on ferroptosis, an iron-dependent form of cell death, and its profound implications in normal physiology and pathological conditions such as cancer and liver disease. We employ an integrative approach in our research. This includes functional genomic screens, metabolomics, bioengineering, and biochemical methodologies, as well as a range of in vitro and in vivo models. We are committed to pushing the boundaries of knowledge in this domain, fostering interdisciplinary collaborations, and translating our discoveries to inform new therapies.
Featured News
-
Tue, Jun 16, 2026
Congratulations to Dr Whitney Henry on being named a 2026 Pew Biomedical Scholar. Dr Henry is one of 21 early-career scientists selected for the 2026 class. The award will support the Henry lab’s work investigating how ferroptosis contributes to liver injury and regeneration. -
Wed, Apr 29, 2026
Congratulations to Dr Whitney Henry on being named a 2026 Searle Scholar. Dr Henry is one of two MIT early-career scientists – and one of 15 scientists overall – selected for the 2026 class by the Searle Scholars Program, which provides funding to support innovative research. -
Tue, Jan 27, 2026
A study from the Henry lab and colleagues reveals that ether lipids regulate iron uptake to shape cancer cell fate and ferroptosis vulnerability. -
Wed, Oct 01, 2025
The Henry lab is excited to officially join the HHMI community! Dr Whitney Henry begins her appointment today as a 2025 HHMI Freeman Hrabowski Scholar.